Eszopiclone 1 mg

DRUG3 trials

Sponsors

Eisai Co., Ltd., Central South University

Conditions

Chronic Insomnia DisorderInsomniaPrimary Insomnia

Phase 1

A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)

CompletedNCT01055834

Eisai Co., Ltd.Insomnia

Start: 2010-01-31End: 2010-02-28Updated: 2013-02-12

Phase 2

A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)

CompletedNCT00770510

Eisai Co., Ltd.Primary Insomnia

Start: 2008-09-30End: 2010-05-31Updated: 2013-02-04

Unknown Phase

Modified Suanzaoren Decoction Versus Eszopiclone for the Treatment of Chronic Insomnia Disorder

CompletedNCT06452953

Central South UniversityChronic Insomnia Disorder

Start: 2020-09-10End: 2024-03-01Updated: 2024-06-11

Related Papers

Clinical efficacy of modified suanzaoren decoction compared to esazolam tablets in the treatment of chronic insomnia disorder

Frontiers in Psychiatry2025-07-242 citations

Altered cerebral functional activity and its associated genetic profiles underlying chronic insomnia disorder before and after treatment

The World Journal of Biological Psychiatry2025-05-182 citations